Bleomycin.
Lazo
J S
JS
Department of Pharmacology, University of Pittsburgh School of Medicine, PA 15261, USA.
Sebti
S M
SM
Schellens
J H
JH
D000964:Antimetabolites, Antineoplastic / Q000009:adverse effects / Q000627:therapeutic use*; D001761:Bleomycin / Q000009:adverse effects / Q000627:therapeutic use*; D004249:DNA Damage; D005609:Free Radicals; D006801:Humans; D012334:RNA, Neoplasm / Q000187:drug effects; D016032:Randomized Controlled Trials as Topic
D000964:Antimetabolites, Antineoplastic; D005609:Free Radicals; D012334:RNA, Neoplasm; D001761:Bleomycin